Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The experimental design is an open-label two-week trial of tolcapone to evaluate which
clinical domains are affected by tolcapone treatment and to identify "responders" to
tolcapone treatment in the two subject groups (BI and NCD)